Amgen

AMGN

Market cap $197B

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

GSK ​and Amgen ‌will add ​their ​medicines to ⁠TrumpRX, ​the prescription ​drug website launched ​by ​President Donald ‌Trump's ⁠administration, Fox Business ​reported ​on ⁠Friday.

Despite the war in the Middle East, Amgen is trading near its 52-week high. One of the reasons is the strong growth in sales of its flagships in the oncology and cardiovascular franchises. So, Imdelltra, a drug used to treat extensive-stage small cell lung cancer, generated $234 million in net revenues for Amgen, up 249.3% year-over-year.

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC's Halftime Report this week about large-cap biotech: “These are growth stocks where you don't have to worry about disruption.

Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 Transcript

Wall Street is drawing fresh lines across the large-cap biopharma landscape. Jefferies initiated coverage on Gilead Sciences Inc.

ALLO, SBUX and AMGN highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Novo Nordisk is a top player in the weight loss market and has several more products on the way. Amgen's most advanced candidate in this space could earn approval in the coming years.

THOUSAND OAKS, Calif., March 5, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference at 9:20 a.m.

Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?